Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

被引:841
作者
Yamamoto, A [1 ]
Lucas, JJ [1 ]
Hen, R [1 ]
机构
[1] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
关键词
D O I
10.1016/S0092-8674(00)80623-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative disorders like Huntington's disease (HD) are characterized by progressive and putative irreversible clinical and neuropathological symptoms, including neuronal protein aggregates. Conditional transgenic models of neurodegenerative diseases therefore could be a powerful means to explore the relationship between mutant protein expression and progression of the disease. We have created a conditional model of HD by using the tet-regulatable system. Mice expressing a mutated huntingtin fragment demonstrate neuronal inclusions, characteristic neuropathology, and progressive motor dysfunction. Blockade of expression in symptomatic mice leads to a disappearance of inclusions and an amelioration of the behavioral phenotype. We thus demonstrate that a continuous influx of the mutant protein is required to maintain inclusions and symptoms, raising the possibility that HD may be reversible.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 54 条
  • [1] Ubiquitin, cellular inclusions and their role in neurodegeneration
    Alves-Rodrigues, A
    Gregori, L
    Figueiredo-Pereira, ME
    [J]. TRENDS IN NEUROSCIENCES, 1998, 21 (12) : 516 - 520
  • [2] STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT
    AMBROSE, CM
    DUYAO, MP
    BARNES, G
    BATES, GP
    LIN, CS
    SRINIDHI, J
    BAXENDALE, S
    HUMMERICH, H
    LEHRACH, H
    ALTHERR, M
    WASMUTH, J
    BUCKLER, A
    CHURCH, D
    HOUSMAN, D
    BERKS, M
    MICKLEM, G
    DURBIN, R
    DODGE, A
    READ, A
    GUSELLA, J
    MACDONALD, ME
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (01) : 27 - 38
  • [3] Dopamine D-1 and D-2 receptor gene expression in the striatum in Huntington's disease
    Augood, SJ
    Faull, RLM
    Emson, PC
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (02) : 215 - 221
  • [4] REDUCED BASAL GANGLIA VOLUME ASSOCIATED WITH THE GENE FOR HUNTINGTONS-DISEASE IN ASYMPTOMATIC AT-RISK PERSONS
    AYLWARD, EH
    BRANDT, J
    CODORI, AM
    MANGUS, RS
    BARTA, PE
    HARRIS, GJ
    [J]. NEUROLOGY, 1994, 44 (05) : 823 - 828
  • [5] Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes
    Bäckman, L
    Robins-Wahlin, TB
    Lundin, A
    Ginovart, N
    Farde, L
    [J]. BRAIN, 1997, 120 : 2207 - 2217
  • [6] COREGULATION OF 2 GENE ACTIVITIES BY TETRACYCLINE VIA A BIDIRECTIONAL PROMOTER
    BARON, U
    FREUNDLIEB, S
    GOSSEN, M
    BUJARD, H
    [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (17) : 3605 - 3606
  • [7] Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
    Becher, MW
    Kotzuk, JA
    Sharp, AH
    Davies, SW
    Bates, GP
    Price, DL
    Ross, CA
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 4 (06) : 387 - 397
  • [8] Carter RJ, 1999, J NEUROSCI, V19, P3248
  • [9] Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
    Cha, JHJ
    Frey, AS
    Alsdorf, SA
    Kerner, JA
    Kosinski, CM
    Mangiarini, L
    Penney, JB
    Davies, SW
    Bates, GP
    Young, AB
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 981 - 989
  • [10] Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
    Cha, JHJ
    Kosinski, CM
    Kerner, JA
    Alsdorf, SA
    Mangiarini, L
    Davies, SW
    Penney, JB
    Bates, GP
    Young, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 6480 - 6485